172 related articles for article (PubMed ID: 15456267)
1. Subtype selective substrates for histone deacetylases.
Heltweg B; Dequiedt F; Marshall BL; Brauch C; Yoshida M; Nishino N; Verdin E; Jung M
J Med Chem; 2004 Oct; 47(21):5235-43. PubMed ID: 15456267
[TBL] [Abstract][Full Text] [Related]
2. N(epsilon)-methanesulfonyl-lysine as a non-hydrolyzable functional surrogate for N(epsilon)-acetyl-lysine.
Jamonnak N; Fatkins DG; Wei L; Zheng W
Org Biomol Chem; 2007 Mar; 5(6):892-6. PubMed ID: 17340003
[TBL] [Abstract][Full Text] [Related]
3. Kinetics and comparative reactivity of human class I and class IIb histone deacetylases.
Schultz BE; Misialek S; Wu J; Tang J; Conn MT; Tahilramani R; Wong L
Biochemistry; 2004 Aug; 43(34):11083-91. PubMed ID: 15323567
[TBL] [Abstract][Full Text] [Related]
4. Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors.
Khan N; Jeffers M; Kumar S; Hackett C; Boldog F; Khramtsov N; Qian X; Mills E; Berghs SC; Carey N; Finn PW; Collins LS; Tumber A; Ritchie JW; Jensen PB; Lichenstein HS; Sehested M
Biochem J; 2008 Jan; 409(2):581-9. PubMed ID: 17868033
[TBL] [Abstract][Full Text] [Related]
5. NAD+-dependent deacetylation of H4 lysine 16 by class III HDACs.
Vaquero A; Sternglanz R; Reinberg D
Oncogene; 2007 Aug; 26(37):5505-20. PubMed ID: 17694090
[TBL] [Abstract][Full Text] [Related]
6. Members of the histone deacetylase superfamily differ in substrate specificity towards small synthetic substrates.
Riester D; Wegener D; Hildmann C; Schwienhorst A
Biochem Biophys Res Commun; 2004 Nov; 324(3):1116-23. PubMed ID: 15485670
[TBL] [Abstract][Full Text] [Related]
7. Factors affecting the substrate specificity of histone deacetylases.
Riester D; Hildmann C; Grünewald S; Beckers T; Schwienhorst A
Biochem Biophys Res Commun; 2007 Jun; 357(2):439-45. PubMed ID: 17428445
[TBL] [Abstract][Full Text] [Related]
8. Preparation of enzymatically active recombinant class III protein deacetylases.
North BJ; Schwer B; Ahuja N; Marshall B; Verdin E
Methods; 2005 Aug; 36(4):338-45. PubMed ID: 16091304
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity studies on suramin analogues as inhibitors of NAD+-dependent histone deacetylases (sirtuins).
Trapp J; Meier R; Hongwiset D; Kassack MU; Sippl W; Jung M
ChemMedChem; 2007 Oct; 2(10):1419-31. PubMed ID: 17628866
[TBL] [Abstract][Full Text] [Related]
10. N(epsilon)-Modified lysine containing inhibitors for SIRT1 and SIRT2.
Huhtiniemi T; Suuronen T; Lahtela-Kakkonen M; Bruijn T; Jääskeläinen S; Poso A; Salminen A; Leppänen J; Jarho E
Bioorg Med Chem; 2010 Aug; 18(15):5616-25. PubMed ID: 20630764
[TBL] [Abstract][Full Text] [Related]
11. Capillary electrophoresis-based sirtuin assay using non-peptide substrates.
Fan Y; Hense M; Ludewig R; Weisgerber C; Scriba GK
J Pharm Biomed Anal; 2011 Mar; 54(4):772-8. PubMed ID: 21074959
[TBL] [Abstract][Full Text] [Related]
12. Nonisotopic substrate for assaying both human zinc and NAD+-dependent histone deacetylases.
Heltweg B; Dequiedt F; Verdin E; Jung M
Anal Biochem; 2003 Aug; 319(1):42-8. PubMed ID: 12842105
[TBL] [Abstract][Full Text] [Related]
13. Mechanism-based inhibition of Sir2 deacetylases by thioacetyl-lysine peptide.
Smith BC; Denu JM
Biochemistry; 2007 Dec; 46(50):14478-86. PubMed ID: 18027980
[TBL] [Abstract][Full Text] [Related]
14. Nepsilon-thioacetyl-lysine: a multi-facet functional probe for enzymatic protein lysine Nepsilon-deacetylation.
Fatkins DG; Monnot AD; Zheng W
Bioorg Med Chem Lett; 2006 Jul; 16(14):3651-6. PubMed ID: 16697640
[TBL] [Abstract][Full Text] [Related]
15. Acetyl-lysine analog peptides as mechanistic probes of protein deacetylases.
Smith BC; Denu JM
J Biol Chem; 2007 Dec; 282(51):37256-65. PubMed ID: 17951578
[TBL] [Abstract][Full Text] [Related]
16. Substrate specificity of SIRT1-catalyzed lysine Nepsilon-deacetylation reaction probed with the side chain modified Nepsilon-acetyl-lysine analogs.
Jamonnak N; Hirsch BM; Pang Y; Zheng W
Bioorg Chem; 2010 Feb; 38(1):17-25. PubMed ID: 19914676
[TBL] [Abstract][Full Text] [Related]
17. Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1.
Napper AD; Hixon J; McDonagh T; Keavey K; Pons JF; Barker J; Yau WT; Amouzegh P; Flegg A; Hamelin E; Thomas RJ; Kates M; Jones S; Navia MA; Saunders JO; DiStefano PS; Curtis R
J Med Chem; 2005 Dec; 48(25):8045-54. PubMed ID: 16335928
[TBL] [Abstract][Full Text] [Related]
18. SIRTUIN 1: regulating the regulator.
Zschoernig B; Mahlknecht U
Biochem Biophys Res Commun; 2008 Nov; 376(2):251-5. PubMed ID: 18774777
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human sirtuins by in situ generation of an acetylated lysine-ADP-ribose conjugate.
Asaba T; Suzuki T; Ueda R; Tsumoto H; Nakagawa H; Miyata N
J Am Chem Soc; 2009 May; 131(20):6989-96. PubMed ID: 19413317
[TBL] [Abstract][Full Text] [Related]
20. Substrate and inhibitor specificity of class 1 and class 2 histone deacetylases.
Hildmann C; Wegener D; Riester D; Hempel R; Schober A; Merana J; Giurato L; Guccione S; Nielsen TK; Ficner R; Schwienhorst A
J Biotechnol; 2006 Jun; 124(1):258-70. PubMed ID: 16567013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]